While GLP-1 medications like semaglutide are not approved specifically for menopause symptoms, emerging research and clinical observation suggest they may help manage the weight and metabolic consequences that often accompany this life transition
Isn't it
Common adverse events were similar to those reported for selective GLP-1RA, including nausea, vomiting, diarrhea, and constipation, which were more frequent at higher doses
Other tests that may be ordered include: blood and urine tests to look for infection a liver enzyme test to check for liver disease a stool test to check for infection in people with diarrhea a pregnancy test to eliminate pregnancy as a cause Your treatment will depend on whether your symptoms are mild or severe
A genuinely smaller appetite tends to persist, which is what supports steady progress on the medication
Animal Studies: Topical GHK-Cu In Living Models Animal models typically rodents bridge the gap between cell culture and human application